Cargando…
Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin
BACKGROUND: Resistance to chemotherapy continues to be a challenge when treating epithelial ovarian cancer (EOC), contributing to low patient survival rates. While CA125, the conventional EOC biomarker, has been useful in monitoring patients’ response to therapy, there are no biomarkers used to pred...
Autores principales: | Gerber, Emma, Asare-Werehene, Meshach, Reunov, Arkadiy, Burger, Dylan, Le, Tien, Carmona, Euridice, Mes-Masson, Anne-Marie, Tsang, Benjamin K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841140/ https://www.ncbi.nlm.nih.gov/pubmed/36642715 http://dx.doi.org/10.1186/s13048-022-01086-x |
Ejemplares similares
-
The Application of an Extracellular Vesicle-Based Biosensor in Early Diagnosis and Prediction of Chemoresponsiveness in Ovarian Cancer
por: Asare-Werehene, Meshach, et al.
Publicado: (2023) -
Pre-operative Circulating Plasma Gelsolin Predicts Residual Disease and Detects Early Stage Ovarian Cancer
por: Asare-Werehene, Meshach, et al.
Publicado: (2019) -
The exosome-mediated autocrine and paracrine actions of plasma gelsolin in ovarian cancer chemoresistance
por: Asare-Werehene, Meshach, et al.
Publicado: (2019) -
Plasma Gelsolin Confers Chemoresistance in Ovarian Cancer by Resetting the Relative Abundance and Function of Macrophage Subtypes
por: Asare-Werehene, Meshach, et al.
Publicado: (2022) -
Exosomal Plasma Gelsolin Is an Immunosuppressive Mediator in the Ovarian Tumor Microenvironment and a Determinant of Chemoresistance
por: Onuma, Toshimichi, et al.
Publicado: (2022)